NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $420,930 | -65.3% | 16,559 | -50.7% | 0.04% | -52.7% |
| Q1 2023 | $1,214,459 | +61.8% | 33,595 | +77.2% | 0.07% | +51.0% |
| Q4 2022 | $750,737 | +48.7% | 18,958 | +64.5% | 0.05% | +81.5% |
| Q2 2022 | $505,000 | -27.1% | 11,528 | +20.4% | 0.03% | -25.0% |
| Q1 2022 | $693,000 | +0.1% | 9,577 | +12.2% | 0.04% | -14.3% |
| Q4 2021 | $692,000 | +6.1% | 8,539 | +52.4% | 0.04% | +13.5% |
| Q3 2021 | $652,000 | -14.8% | 5,603 | +21.4% | 0.04% | -9.8% |
| Q2 2021 | $765,000 | +60.0% | 4,617 | +34.9% | 0.04% | +51.9% |
| Q1 2021 | $478,000 | -8.1% | 3,423 | +13.9% | 0.03% | -28.9% |
| Q4 2020 | $520,000 | -79.8% | 3,005 | -83.8% | 0.04% | -54.8% |
| Q3 2020 | $2,580,000 | +73.2% | 18,521 | +48.5% | 0.08% | +121.1% |
| Q2 2020 | $1,490,000 | +87.2% | 12,474 | +56.7% | 0.04% | +81.0% |
| Q1 2020 | $796,000 | -16.6% | 7,959 | -2.0% | 0.02% | +61.5% |
| Q4 2019 | $955,000 | +7.7% | 8,123 | -21.3% | 0.01% | +30.0% |
| Q3 2019 | $887,000 | – | 10,316 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
| Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
| Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
| Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
| ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
| FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
| PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
| FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
| Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
| K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |